Pfizer/Pharmacia merger
This article was originally published in The Tan Sheet
Executive Summary
Firms "have substantially narrowed the remaining open matters with both" FTC and European regulatory authorities "to a relatively small number of issues," Pfizer and Pharmacia report Dec. 5. Companies are "confident" transaction will close in first quarter 2003; original target had been year end (1"The Tan Sheet" July 22, 2002, p. 8). Pfizer shareholders voted to approve the deal Dec. 6...
You may also be interested in...
Pfizer/Pharmacia OTC Motion Sickness Stronghold Could Make FTC Queasy
Pfizer's acquisition of Pharmacia likely will draw antitrust regulatory scrutiny to one of the combined firm's smallest product lines - OTC motion sickness tablets
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.